InvestorsHub Logo
Followers 20
Posts 1676
Boards Moderated 0
Alias Born 07/09/2005

Re: None

Wednesday, 02/20/2019 5:19:24 PM

Wednesday, February 20, 2019 5:19:24 PM

Post# of 796
Seems Management has more faith in the company than does the market. The years i've owned/traded $VSTM, Management has not disappointed yet.

Verastem Oncology Announces Key Management Appointments

“Verastem Oncology continues to grow our operations across the U.S. in crucial functional areas, such as commercial management, clinical development, medical affairs, regulatory, quality assurance and investor relations and communications,” said Robert Forrester, President and Chief Executive Officer of Verastem Oncology. “We are delighted to welcome Amy, Bob and Erin to our team to support us in our mission of bringing new cancer therapies to patients and families battling these devastating diseases. We will greatly benefit from Amy’s successful product launch expertise and deep knowledge of the b-cell malignancies space. Bob is also an important addition that will help guide the organization and advancement of our pipeline of therapies to late-stage development. Erin’s extensive IR and communications experience in the biotechnology industry will be critical as we continue to increase our presence within the financial community.”

https://seekingalpha.com/pr/17417540-correcting-replacing-verastem-oncology-announces-key-management-appointments
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VSTM News